EpiShuttle Approved in Australia!
EpiGuard is proud to announce that the EpiShuttle has been approved by the Therapeutic Goods Administration (TGA) and is now available for use in the Australian market!
Our Quality and Assurance work: focus on NoMA audit
EpiGuard’s commitment to safety and quality was attested by our successful completion of an audit by the Norwegian Medicines Agency last June.
New EpiGuard CEO – Michael Eimstad
It’s been an exciting summer at EpiGuard, with the launch of our new e-Learning platform and the appointment of our new CEO, Michael Eimstad.
Prepared for Next Disease X with EpiShuttle E-learning!
Be prepared for next Disease X! EpiShuttle e-learning will make patient isolation and transportation safer and more efficient!
Meet our Heroes – Andreas, Fridtjof, and Carl!
Meet EpiGuard heroes – three brave men on the front line helping people of Ukraine.
Finland ups Pandemic and CBRNe Preparedness with EpiShuttles
Finland is investing in the future safety of their citizens by increasing national preparedness for pandemics and CBRNe events with EpiShuttles!
EpiGuard partners up with Leader Healthcare
EpiGuard is proud to announce a new exclusive partnership with Leader Healthcare Group!